| Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | |
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Operating income | |||
| Operating margin | |||
| Net income | |||
| Net profit margin | |||
| Cash on hand | |||
| Change in cash | |||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 2.45 k | 2.45 k | 2.45 k | 2.45 k | 2.45 k | |
| Cash burn (monthly) | 10.97 k | 24.35 k | 426.33 k | 180.24 k | 26.30 k | |
| Cash used (since last report) | 195.23 k | 433.31 k | 7.59 mm | 3.21 mm | 467.95 k | |
| Cash remaining | -192.77 k | -430.85 k | -7.58 mm | -3.20 mm | -465.50 k | |
| Runway (months of cash) | -17.6 | -17.7 | -17.8 | -17.8 | -17.7 | |
| 13F holders | Current |
|---|---|
| Total holders | 62 |
| Opened positions | 18 |
| Closed positions | 3 |
| Increased positions | 17 |
| Reduced positions | 2 |
| 13F shares | Current |
|---|---|
| Total value | 132.19 bn |
| Total shares | 30.11 mm |
| Total puts | 0.00 |
| Total calls | 224.21 k |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| BioPlus Sponsor | 6.63 mm | $70.15 mm |
| Fitzgerald Securities Cantor | 1.60 mm | $0.00 |
| Linden Advisors | 1.50 mm | $10.86 bn |
| Westchester Capital Management | 1.39 mm | $15.05 bn |
| Cowen And | 1.20 mm | $7.39 bn |
| WRB W. R. Berkley | 1.12 mm | $12.13 bn |
| Periscope Capital | 1.12 mm | $2.76 bn |
| Vivaldi Asset Management | 1.11 mm | $11.99 bn |
| Saba Capital Management | 1.08 mm | $3.56 bn |
| Polar Asset Management Partners | 941.93 k | $3.72 bn |
